Adjuvant medical therapies after portoenterostomy for biliary atresia: time for randomized controlled trial.
DeRusso
Patricia A
PA
Division of Pediatric Gastroenterology and Nutrition, Johns Hopkins School of Medicine, Baltimore, MD, USA.
D001656:Biliary Atresia / Q000188:drug therapy* / Q000601:surgery*; D001663:Bilirubin / Q000097:blood; D003131:Combined Modality Therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D011171:Portoenterostomy, Hepatic; D016032:Randomized Controlled Trials as Topic; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D005938:Glucocorticoids; D014580:Ursodeoxycholic Acid; D001663:Bilirubin